Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Bad neighbors: arsenic-induced tumor cells convert normal stem cells into a cancerous phenotype.

Barrett JR.

Environ Health Perspect. 2012 Jun;120(6):A244. doi: 10.1289/ehp.120-a244a. No abstract available.

2.

Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype.

Xu Y, Tokar EJ, Sun Y, Waalkes MP.

Environ Health Perspect. 2012 Jun;120(6):865-71. doi: 10.1289/ehp.1204987. Epub 2012 Apr 4.

3.

Dynamics of notch expression during murine prostate development and tumorigenesis.

Shou J, Ross S, Koeppen H, de Sauvage FJ, Gao WQ.

Cancer Res. 2001 Oct 1;61(19):7291-7.

4.

Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.

Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP.

Toxicol Appl Pharmacol. 2005 Aug 15;206(3):288-98. Epub 2005 Jan 18.

PMID:
16039940
5.

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

Ahmed N, Abubaker K, Findlay J, Quinn M.

Curr Cancer Drug Targets. 2010 May;10(3):268-78. Review.

PMID:
20370691
6.

Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.

Natarajan TG, Ganesan N, Fitzgerald KT.

Cancer Biomark. 2010;9(1-6):65-99. doi: 10.3233/CBM-2011-0173. Review.

PMID:
22112470
7.
9.

17-Beta-estradiol induces neoplastic transformation in prostatic epithelial cells.

Yu S, Zhang Y, Yuen MT, Zou C, Danielpour D, Chan FL.

Cancer Lett. 2011 May 1;304(1):8-20. doi: 10.1016/j.canlet.2011.01.003. Epub 2011 Feb 25.

PMID:
21353741
10.

Cadmium-induced neoplastic transformation of human prostate epithelial cells.

Nakamura K, Yasunaga Y, Ko D, Xu LL, Moul JW, Peehl DM, Srivastava S, Rhim JS.

Int J Oncol. 2002 Mar;20(3):543-7.

PMID:
11836566
11.
12.

[Effect of Aurora A on biological phenotypes of prostate cancer cells].

Zhao FY, Qu Y, Zhang L, Mu DZ, Huang X, Wei DP.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Mar;38(2):302-5. Chinese.

PMID:
17441355
14.

Altered growth regulation and loss of response to retinoic acid accompany tumorigenic transformation of prostatic cells.

Peehl DM, Sellers RG, Arnstein P, Kung HF, Rhim JS.

Anticancer Res. 1999 Sep-Oct;19(5B):3857-64.

PMID:
10628324
15.
16.

Cancer stem cells: a step toward the cure.

Boman BM, Wicha MS.

J Clin Oncol. 2008 Jun 10;26(17):2795-9. doi: 10.1200/JCO.2008.17.7436. No abstract available.

PMID:
18539956
17.

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.

Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC.

Cancer Res. 2004 Dec 15;64(24):8867-75.

18.

Proteomic analysis of cancer stem cells in human prostate cancer cells.

Lee EK, Cho H, Kim CW.

Biochem Biophys Res Commun. 2011 Aug 26;412(2):279-85. doi: 10.1016/j.bbrc.2011.07.083. Epub 2011 Jul 28.

PMID:
21820414
19.

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.

Vainio P, Wolf M, Edgren H, He T, Kohonen P, Mpindi JP, Smit F, Verhaegh G, Schalken J, Perälä M, Iljin K, Kallioniemi O.

Prostate. 2012 May 15;72(7):789-802. doi: 10.1002/pros.21487. Epub 2011 Sep 14.

PMID:
21919029
20.

Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.

Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA, Lichtinghagen R.

Prostate. 2002 Jan 1;50(1):38-45.

PMID:
11757034

Supplemental Content

Support Center